Boosted by a recent dose of funding, Carmel-based Confluence Pharmaceuticals is taking aim at Phase 2 clinical trials for its drug, which company leaders believe will restore hope and unlock potential... Read More
Chest pain is the second most common reason people rush to the emergency room (ER), but only one in five patients is actually having a cardiac event. The vast majority of people with chest pain are se... Read More
Warsaw-based Zimmer Biomet Holdings Inc. (NYSE: ZBH) has selected Vafa Jamali as chief executive officer of NewCo, the spine and dental businesses of Zimmer Biomet that will spin off into an independe... Read More
New Jersey-based J. Knipper and Company Inc. says it plans to invest $17.4 million to expand its distribution center located in the River Ridge Commerce Center and grow its workforce by 38 people. Kni... Read More
Indianapolis-based Apria Inc. (Nasdaq: APR) has begun listing on the Nasdaq Global Select Market after an Initial Public Offering this week. The home healthcare equipment provider is looking to raise... Read More
West Lafayette-based Bioanalytical Systems Inc. (Nasdaq: BASI) is reporting a fiscal first quarter net loss of $366,000, compared to a loss of $1.4 million during the same period the previous year. Ch... Read More
The U.S. Food and Drug Administration has granted an Emergency Use Authorization for two COVID-19 antibody therapies from Indianapolis-based Eli Lilly and Co. (NYSE: LLY). The company says the combina... Read More
A West Lafayette-based biotechnology startup has closed on a $5.5 million Series A round of funding. Novosteo Inc., which is developing compounds to treat bone fractures and other bone diseases, has a... Read More
Indianapolis-based Eli Lilly and Co. (NYSE: LLY) is partnering with local health systems to launch dedicated infusion centers throughout the state. The centers are designed to provide residents with a... Read More
A $37.6 million grant is powering a newly-formed consortium tasked with developing DNA-encoded antibodies, which can kill a COVID-19 infection faster than antibody treatments that don’t have the power... Read More
A new study is now underway for bamlanivimab; retrofitted RVs will travel to the diverse state of New Mexico to turn any location into, essentially, a clinical research facility on wheels.... Read More
An Indiana University researcher has long been concerned about the cumulative effect of more elusive injuries for young people: subconcussive head impacts.... Read More
You can do good business and also do ‘Good’: that’s the theory behind a new Cook Medical facility that will bring 100 new jobs and free education to a struggling Indianapolis community.... Read More
The National Science Foundation has awarded a $256,000 grant to a West Lafayette-based startup to help in the fight against COVID-19. Akanocure Pharmaceuticals Inc. says it will use the funding to fur... Read More
Indianapolis-based Performance Validation Inc. is adding to its portfolio. The company, which provides commissioning, qualification and validation services for pharmaceutical, biotechnology and medica... Read More
The USA general manager for New Jersey-based Advanced Accelerator Applications says the company chose Indianapolis for its planned $72 million manufacturing facility because of the unique nature of th... Read More
Greenfield-based Elanco Animal Health Inc. (NYSE: ELAN) says it will cut about 350 jobs globally, including 50 in Indiana, as part of an ongoing restructuring effort. The company says the move aims to... Read More
Indianapolis-based Eli Lilly and Co. has released the results of another Phase 3 trial of its COVID-19 antibody therapies. The company says the combination of its therapies bamlanivimab and etesvimab... Read More
Two Indiana companies are teaming up on the development of a metal technology to be used in medical devices. Warsaw-based Nextremity Solutions Inc. says it has entered into an exclusive supply agreeme... Read More
Indianapolis-based Eli Lilly and Co. (NYSE: LLY) says its COVID-19 antibody therapy is showing success in reducing the risk of contracting the disease among residents and staff of long-term care facil... Read More
